Skip NavigationSkip to Content

Pharmacokinetics of dacarbazine (DTIC) in pregnancy

  1. Author:
    Kantrowitz-Gordon, Ira
    Hays, Karen
    Kayode, Olumide
    Kumar, Aditya R.
    Kaplan, Henry G.
    Reid, Joel M.
    Safgren, Stephanie L.
    Ames, Matthew M.
    Easterling, Thomas R.
    Hebert, Mary F.
  2. Author Address

    Univ Washington, Dept Family & Child Nursing, 1959 NE Pacific St, Seattle, WA 98195 USA.Univ Washington, Dept Pharm, 1959 NE Pacific St, Seattle, WA 98195 USA.Univ Washington, Dept Obstet & Gynecol, 1959 NE Pacific St, Seattle, WA 98195 USA.NCI, Ctr Canc Res, 8560 Progress Dr, Frederick, MD 21702 USA.Mayo Clin, Grad Sch Biomed Sci, Dept Mol Pharmacol & Expt Therapeut, 200 First St SW, Rochester, MN 55905 USA.Swedish Med Ctr, Swedish Canc Inst, 1221 Madison St 500, Seattle, WA 98104 USA.
    1. Year: 2018
    2. Date: Mar
  1. Journal: Cancer Chemotherapy and Pharmacology
  2. SPRINGER,
    1. 81
    2. 3
    3. Pages: 455-460
  3. Type of Article: Article
  4. ISSN: 0344-5704
  1. Abstract:

    The purpose of this report is to describe, for the first time, the pharmacokinetics of dacarbazine (DTIC) and its metabolites [5-[3-methyl-triazen-1-yl]-imidazole-4-carboxamide (MTIC), 5-[3-hydroxymethyl-3-methyl-triazen-1-yl]-imidazole-4-carboxamide (HMMTIC) and 5-aminoimidazole-4-carboxamide (AIC)] during pregnancy (n = 2) and postpartum (n = 1).

    See More

External Sources

  1. DOI: 10.1007/s00280-017-3511-6
  2. PMID: 29305638
  3. PMCID: PMC5828904
  4. WOS: 000426060100003

Library Notes

  1. Fiscal Year: FY2017-2018
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel